Radioresistance of Non-Small Cell Lung Cancers and Therapeutic Perspectives

Radioresistance of Non-Small Cell Lung Cancers and Therapeutic Perspectives

Survival in unresectable locally advanced stage non-small cell lung cancer (NSCLC) patients remains poor despite chemoradiotherapy. Recently, adjuvant immunotherapy improved survival for these patients but we are still far from curing most of the patients with only a 57% survival remaining at 3 year...

Full description

Bibliographic Details
Main Authors: Mathieu Césaire, Juliette Montanari, Hubert Curcio, Delphine Lerouge, Radj Gervais, Pierre Demontrond, Jacques Balosso, François Chevalier
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
non-small-cell lung cancer
cancer stem cell
cancer mutation
radiotherapy
immunotherapy
proton irradiation
Online Access:https://www.mdpi.com/2072-6694/14/12/2829

Internet

https://www.mdpi.com/2072-6694/14/12/2829

Similar Items